Clinical predictors of subtherapeutic aminoglycoside levels in trauma patients undergoing once-daily dosing

Journal of Trauma

Volumn 55, Issue 2, 2003, Pages 255-262

  Toschlog, Eric A ^a   Blount, Kennedy P ^a   Rotondo, Michael F ^a   Sagraves, Scott G ^a   Bard, Michael R ^a   Schenarts, Paul J ^a   Swanson, Melvin ^a   Goettler, Claudia E ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Aminoglycosides; Creatinine clearance; Once daily dosing; Trauma; Volume of distribution

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT;

ADULT; AGE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; CRITICAL ILLNESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; WOUNDS AND INJURIES;

EID: 0041319017     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000079367.23481.8D     Document Type: Article

References (24)

1. Anaizi N. Once-daily dosing of aminoglycosides: a consensus document. Int J Clin Phamacol Ther. 1997; 35: 223-226.
2. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995; 39: 650-655.
3. Chuck SK, Raber SR, Rodvold KA, Areff D. National survey of extended-interval aminoglycoside dosing. Clin Infect Dis. 2000; 30: 433-439.
4. Ryback MJ, Abate BJ, Kang SL, Ruffling MJ, Lerner SA, Drusano GL. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother. 1999; 43: 1549-1555.
5. Sorger JI, Kirk PG, Ruhnke CJ, et al. Once-daily, high dose versus divided, low dose gentamicin for open fractures. Clin Orthop. 1999; 366: 197-204.
6. Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997; 24: 796-809.
7. Bailey TC, Little JR, Littenberg B, Reichley RM, Dunagan WC. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997; 24: 786-795.
8. Ferriols-Lisart R, Alos-Alminana M. Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. Am J Health Syst Pharm. 1996; 53: 1141-1150.
9. Bates RD, Nahata MC. Once-daily administration of aminoglycosides. Ann Pharmacother. 1994; 28: 757-766.
10. Fisman DN, Kaye KM. Once-daily dosing of aminoglycoside antibiotics. Infect Dis Clin North Am. 2000; 14: 475-487.
11. Bujik SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Intensive Care Med. 2002; 28: 936-942.
12. Brusco L, Talbert S, Wedderburn RV. Once-daily aminoglycoside dosing protocol results in inadequate gentamicin levels in surgical intensive care unit patients with normal renal function. Crit Care Med. 1999; 27 (suppl): A138.
13. Dwivedi A, Jucha J, Czerwinski C, Tennenberg S. Once-daily aminoglycoside dosing in surgical ICU patients fails to achieve therapeutic target peak levels. Crit Care Med. 1999; 27 (suppl): A138.
14. Wolfe TA, Dasta JF, Reilley TE, Flancbaum LJ. Assessment of the appropriateness of once-daily aminoglycoside dosing in surgical intensive care unit patients. Crit Care Med. 1998 (suppl): A99.
15. Reichert MG, Neudeck BL, Welage LS. Critical appraisal of serum concentration monitoring of single-daily dose aminoglycoside therapy in critically ill patients. Pharmacotherapy. 1998; 18: 1144.
16. Barletta JF, Johnson FB, Nix DE, Nix LC, Erstad BL. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. J Trauma. 2000; 49: 869-872.
17. Finnell DL, Davis GA, Cropp CD, Ensom MH. Validation of the Hartford nomogram in trauma surgery patients. Ann Pharmacother. 1998; 32: 417-421.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
19. Sickels JM, Hawes M. Pharmacokinetic variability in patients receiving large dose-extended interval aminoglycosides. Pharmacotherapy. 2002; 22: 1366.
20. Lacy MK, Nicolau DP, Nightingale CH, Quintiliani R. The pharmacodynamics of aminoglycosides. Clin Infect Dis. 1998; 27: 23-27.
21. Freeman CD, Nicolau DP, Delliveau PP, Nightingale CH, Ross JW, Quintiliani R. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother. 1997; 39: 67-86.
22. Gault MH, Longerich LL, Harnett JD, Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron. 1992; 62: 249-256.
23. Davis GA, Chandler MH. Comparison of creatinine clearance estimation methods in patients with trauma. Am J Health Syst Pharm. 1996; 53: 1028-1032.
24. Cherry RA, Eachempati SR, Hydo L, Barie PS. Accuracy of short-duration creatinine clearance determinations in predicting 24-hour creatinine clearance in critically ill and injured patients. J Trauma. 2002; 53: 267-271